NCT02721368View on ClinicalTrials.gov

Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

November 3, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

September 11, 2019

Conditions
Aging
Interventions
DEVICE

Neuramis® Volume Lidocaine

hyaluronic acid filler

DEVICE

Juvederm® Voluma® with Lidocaine

hyaluronic acid filler

Trial Locations (1)

156-755

Chung-Ang Univ. Medical Center, Seoul

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT02721368 - Neuramis® Volume Lidocaine Treatment in Patients With Loss of Mid-face Volume | Biotech Hunter | Biotech Hunter